Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802930 · ClinicalTrials.gov registry record · NA
Test the Phototoxicity of Sunscreen Products
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02802930 is a NA study that has completed, run by Bayer. The registered enrollment target is 32 participants.
The verdict
NCT02802930, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The primary objective of this study was to evaluate the potential for phototoxicity of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 compared to that of a negative control (0.9% sodium chloride \[NaCl\]) after a single 24 h application of test materials followed by irradiation with ultraviolet A (UVA) and ultraviolet B (UVB). The secondary objective of this study was to evaluate the safety of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with UVA/B irradiation by monitoring adverse events (AEs) throughout the study.
Interventions
- DRUG SPF 50 Y65 110 (BAY987519)
- DRUG SPF 50 Y51 002 (BAY987519)
- DRUG SPF 15 V27 104 (BAY987519)
- DRUG Sodium chloride [NaCl]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-04-20 |
| Est. Completion | 2015-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802930
The ClinicalTrials.gov registry entry for NCT02802930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which SPF 50 Y65 110 (BAY987519) is the first listed.
NCT02802930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02802930 about?
NCT02802930 is a clinical study titled "Test the Phototoxicity of Sunscreen Products". The primary objective of this study was to evaluate the potential for phototoxicity of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 compared to that of a negative control (0.9% sodium chloride \[NaCl\]) after a single 24 h application of test materials followed by irradia...
What is the current status of trial NCT02802930?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-04-20. Estimated completion is 2015-04-26.
What interventions are being tested in trial NCT02802930?
The interventions under investigation include: SPF 50 Y65 110 (BAY987519) (DRUG), SPF 50 Y51 002 (BAY987519) (DRUG), SPF 15 V27 104 (BAY987519) (DRUG), Sodium chloride [NaCl] (DRUG).
Who is sponsoring clinical trial NCT02802930?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.